Drawdown of Tranche 3 under the Convertible Note Facility
Released
Latest announcements
Ask a question
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this announcement.